No-Cost COVID-19 Testing Ends January 31st

Hidalgo County Public Health Lab to Stop Free COVID 19 Tests Jan. 31st

Community NewsNews
329

Listen to article (english)

Translate to Spanish or other 102 languages!

Beginning February 1, 2026, low-cost laboratory testing services will be available. This includes COVID-19 testing, flu/strep tests, diabetes screenings and much more. Courtesy image. Patient image for illustration purposes
Beginning February 1, 2026, low-cost laboratory testing services will be available. This includes COVID-19 testing, flu/strep tests, diabetes screenings and much more. Courtesy image. Patient image for illustration purposes

Mega Doctor News

- Advertisement -

The Hidalgo County Health & Human Services Department has announced that no-cost COVID-19 testing at the Hidalgo County Public Health Laboratory will conclude on January 31, 2026.

Beginning February 1, 2026, low-cost laboratory testing services will be available. This includes COVID-19 testing, flu/strep tests, diabetes screenings and much more. 

Fees vary by test. Employees and members of the public seeking pricing or appointment information should contact the laboratory directly.

See the image below for more information:

Courtesy image
- Advertisement -
- Advertisement -

Latest news

- Advertisement -
Previous article
MD Anderson Partners with SOPHiA GENETICS to Accelerate Innovation in AI Precision Oncology
Next article
The Importance of Giving the Gift of Life

More Articles

DHR Health Expands Kidney Transplant Program with Transplant Nephrologist, Dr. Victor E. Prado

As part of its ongoing commitment to bringing world-class healthcare to the Rio Grande Valley, DHR Health is pleased to announce the addition of double board-certified transplant nephrologist, Dr. Victor E. Prado. Dr. Prado will provide care to patients at DHR Health’s Transplant Institute,

New Therapy for Head and Neck Squamous Cell Carcinoma Receives Accelerated FDA Approval

The U.S. Food and Drug Administration today granted accelerated approval to Rybrevant Faspro (amivantamab and hyaluronidase-lpuj) for the treatment of adults with recurrent or metastatic head and neck squamous cell carcinoma (HNSCC) whose disease has progressed on or after platinum-based chemotherapy and immunotherapy.

DHR Health to Host 13th Annual Circle of Care Caregivers Conference

DHR Health Rehabilitation Hospital will host its 13th Annual Circle of Care Caregivers Conference on Saturday, November 7, 2026, at the Edinburg Conference Center at Renaissance, offering educational presentations and resources for individuals caring for family members and loved ones.

HHS Opens $1 Million Funding Opportunity to Strengthen Women’s Preventive Care

The U.S. Department of Health and Human Services (HHS), through the Health Resources and Services Administration (HRSA), announced a Notice of Funding Opportunity (NOFO) for the Women’s Initiative for Screening and Health (WISH) program.
- Advertisement -